Cellmid Ltd - New Signed Distribution Agreements
Cellmid Ltd (ASX:CDY)

New Signed Distribution Agreements

Question   What Does It Mean?
Document   View Announcement
Published Oct 02, 2019

What happened?

Europe Expansion:

Cellmid has entered into a supply agreement for its évolis® Professional anti-aging hair care and hair loss products with leading European beauty retailer, Douglas GmbH.

China Expansion:

Cellmid has signed an exclusive distribution agreement with Aeon International for évolis® Professional to be sold in the Chinese cross-border e-commerce market.

Global Growth:

These new channels and partners are expected to continue to drive consumer health revenue growth in Europe and China, in addition to existing geographies.

CEO's summary

Maria Halasz CEO of Cellmid Ltd has provided a statement.
Maria Halasz
Maria Halasz
CEO, Cellmid Ltd

“We are delighted to announce these new distribution and sales channels with quality partners around the world. As we continue to work with our new and existing partners worldwide, it strengthens our confidence in the robust, omnichannel model and growth profile of our consumer health division. We look forward to expanding our product sales in FY2020 and beyond as a result.”

Question   Ask Maria Halasz a question...

Analysts thoughts

SmallCapInsider from Mawson Graham provides perspective on this recent announcement.
SmallCapInsider
Written by SmallCapInsider
Published Oct 02, 2019

We believe that this agreement with Douglas GmbH is evidence that Cellmid is continuing to execute on its omni-channel distribution strategy. As new territories continue to unlock we believe that this will likely lead to increased sales over time, and in turn, help push the company's Advangen subsidiary toward break-even in FY19/20 and beyond over the coming years.

Download Announcement

View this announcement as well as our full profile on the company.
Document   View Announcement
View CDY's Full Profile Arrow Forward

Comments

Share your thoughts about this announcement...
Similar articles
Independent test results for the Wondfo SARS-COV-2 Test
What's happened? Cellmid Limited (ASX:CDY) has announced that a validation study has been completed for the Wondfo SARS-...
3 years ago
Cellmid share placement raises $6m to fund SARS-V-2 diagnostic test roll out
What's happened? Cellmid Limited (ASX:CDY) has raised $6 million (before costs) via a share placement from institutional...
4 years ago
Cellmid enter into supply agreement for COVID-19 rapid diagnostic test
What's happened? Cellmid Ltd (ASX: CDY, “Cellmid”) have announced that it has entered into a supply agreement for a COVI...
4 years ago
Around the web
Closing Bell: ASX down on Beijing tantrum, biotech proves Sandy Beard no rash decision
The S&P/ASX200 is lower in late trade on Tuesday, dropping around 30 points or 0.4%, after iron...
via stockhead.com.au
7 startup founders share the lessons they learned in 2021 that they’ll be applying to the year ahead
2021 didn’t quite turn out way we’d hoped after the initial pandemic chaos on 2020. With the past 12...
via startupdaily.net
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and...
via stockhead.com.au
Powered by  
  • Company
    Cellmid Ltd
  • Website
  • Sector
    Biotechnology
  • Industry
    Biotechnology
  • Code
    ASX:CDY
  • Socials
View Cellmid Ltd's Profile

How do I invest?

Considering investing in Cellmid Ltd?
Here's how to get started.
Low Cost Brokerage ASX Cheapest ASX Trading Platform
  1. 1

    Create account

    Open an account with an online broker of your choice. If you do not have an existing broker, consider Mawson Graham's A$9.50 flat fee platform.

    Sign up now »
  2. 2

    Search for ASX:CDY

    On your online investment platform search for the stock ticker code ASX:CDY to bring up the company's shares.

  3. 3

    Buy shares

    Place your order however you wish. If you need advice on buying or selling, you should seek the assistance of a full service financial adviser experienced in small cap equities.

Trade for $9.50 Arrow Forward
Up